Logo
PFE logo
Pfizer Inc.
PFE
28.45 (-1.28%) 0.37
Market cap
$162.16(B)
Earnings date
Oct-27-2026
Category
Sector
Health Care
Industry
Pharmaceuticals
Pfizer Inc. discovers develops manufactures markets distributes and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma PC1 and Pfizer Ignite. The company offers internal medicine products including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family Abrysvo Nimenrix FSME/IMMUN-TicoVac and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products such as Xeljanz Enbrel Cibinqo Litfulo Eucrisa and Velsipity; rare disease products for therapeutic areas comprising amyloidosis hemophilia and endocrine diseases under the Vyndaqel family Genotropin BeneFIX Xyntha Somavert Ngenla and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta Octagam and Panzyga brands. In addition the company offers oncology products comprising ADCs small molecules bispecific and other immunotherapies for the treatment of cancers including breast cancer genitourinary cancer and hematologic malignancies as well as melanoma gastrointestinal gynecological and lung cancer under the Ibrance Xtandi Padcev Adcetris Inlyta Lorbrena Bosulif Tukysa Braftovi Mektovi Orgovyx Elrexfio Tivdak and Talzenna brands. Further it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit Ruxience Zirabev Trazimera and Nivestym and other biosimilars; and sterile injectables such as Sulperazon Atgam Fragmin Solu Medrol Solu Cortef and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US Inc.; Merck KGaA; and BioNTech SE as well as a strategic collaboration with Boltz PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York New York.
EV: $221.73(B)
Total Equity: $85.49(B)
Debt/Equity: 0.74
Dividend/share: $1.7
Div. yield: 6.05%
P/E: 37.43
Forward P/E: 9.55
P/FCF: 14.74
P/S: 2.54
P/B: 1.90
EPS: $0.8
EPS (fwd): $3.0
FCF/share: $1.9
Revenue/share: $11.2
Book value/share: $14.9
ROIC: 6.3%
ROA: 4.6%
ROE: 10.6%
Margins: Gross | Op. | Net
74.7% | 24.6% | 6.8%
0.0%of Portfolio
My holdings
Day change
Total change
Overview Valuation Growth Financials & KPIsCompetitors & Peer Comparison Ownership ToolsAll
PEvaluation
46%
$41.5
Based on a fair P/E of 14.7x and
forward EPS of $2.83
Valuation summary
Min—
Max—
Average—
Median—
Valuation comparison
Current price$28.4
Quality checklist score
3/8
Based on your selected metrics.
Debt/Equity < 1 Current Ratio > 1 Net Margin > 10%
5Y Shares Out Change < 0% ROIC > 10% Quick Ratio > 1 Past Net Income CAGR > 0% Est. EPS Growth > 5%

TTM Financials

Income (TTM)

RevenueGrossNet
Revenue$63.70(B)
Gross profit$47.59(B)
EBITDA$25.38(B)
Net income$4.33(B)
Gross margin74.7%
Operating margin24.6%
Net margin6.8%
Shares outstanding5.70(B)

Balance sheet

Cash & ST inv.Other ST assetsLong term assetsCurrent liabilitiesLong term debtOther LT liabilitiesEquity
Total assets$201.13(B)
Current assets$41.36(B)
Total liabilities$115.64(B)
Current liabilities$32.65(B)
Cash & Short-term inv.$11.70(B)
Long-term debt$60.77(B)
Total intangibles$118.47(B)
PP&E$19.03(B)

Cash flow (TTM)

CFOCFICFF
FCF$10.98(B)
CapEx$-2.42(B)
Dividends paid$-9.79(B)
Stock issued$0
Stock repurchased$0
Stock-based comp.$947.00(M)
Debt issued$5.99(B)
Debt repaid$-4.21(B)

Per share data (TTM)

Price
Price
$28.4
Income
Revenue
$11.2•2.5x|39.3%
Gross profit
$8.35•3.4x|29.3%
Earnings (EPS)
$0.76•37.4x|2.7%
Cash flow
FCF
$1.93•14.7x|6.8%
Stock-based comp.
$0.17•171.2x|0.6%
CapEx
$0.42•67.1x|1.5%
Dividend
$1.72•16.5x|6.0%
Balance sheet
Total assets
$35.3•0.8x|124.0%
Total liabilities
$20.3•1.4x|71.3%
Book value
$14.9•1.9x|52.5%
Cash & ST inv.
$2.05•13.9x|7.2%
Debt
$10.7•2.7x|37.5%
Forward earnings
EPS FY+1
$2.98•9.5x|10.5%
EPS FY+2
$2.90•9.8x|10.2%
EPS FY+3
$2.47•11.5x|8.7%
EPS FY+4
$2.31•12.3x|8.1%
EPS FY+5
$2.40•11.9x|8.4%
Forward FCF
FCF FY+1
$3.30•8.6x|11.6%
FCF FY+2
$3.28•8.7x|11.5%
FCF FY+3
$3.02•9.4x|10.6%
FCF FY+4
$2.94•9.7x|10.3%
FCF FY+5
$2.73•10.4x|9.6%

Summary

PFE Valuation & Price Targets

Favorite Valuation Methods

PEvaluation
—
Analyst targets
—
DCF (2-stage)
—

More Valuation Methods

DCF (simple)
—
DCF (exit mult.)
—
DDM
—
EPS growth
—
Revenue growth
—
Peter Lynch FV
—
Graham No.
—

PEvaluation

CURRENT PRICE
$28
46% Undervalued
BEAR
$31
10%
BASE
$42
46%
BULL
$52
83%
Fair P/E
Margin of safety
EPS
Market Model
ROICRevenue growthFCF MarginShares outstan...Debt/EquityDebt/EBITDA
Economic moat: Wide

EPS Estimates

LowAvgHigh#
FY+12.93.03.125
FY+22.52.93.125
FY+32.02.52.919
FY+41.82.32.912
FY+51.92.43.112

Analyst Price Targets

CURRENT PRICE
$28
2% Overvalued
BEAR
$25
12%
BASE
$28
2%
BULL
$36
26%

Analyst Recommendations

Strong Buy2
Buy8
Hold16
Sell1
Strong Sell1

2-stage DCF

First Stage Duration: 5 Years
Starting Free Cash Flow
First Stage Growth Rate
Low
Mid
High
Terminal Growth Rate
Low
Mid
High
Discount Rate

Discounted Cash Flow

Forecast years: 5 Years
Terminal Growth Rate
Low
Mid
High
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Discounted Cash Flow (exit mult.)

Forecast years: 5 Years
Exit FCF Multiple
Low
Mid
High
Discount Rate
Free cash flow estimates:
Y+1 est.
Y+2 est.
0.00%
Y+3 est.
0.00%
Y+4 est.
0.00%
Y+5 est.
0.00%

Dividend Discount Model

Annual Dividend
First Stage Length (Years): 0 Years
First Stage Growth Rate
Low
Mid
High
Final Growth Rate
Low
Mid
High
Discount Rate

EPS Growth

Forecast years: 5 Years
Starting EPS
EPS Growth Rate
Low
Mid
High
Final P/E
Low
Mid
High
Discount Rate

Revenue Growth Valuation

Forecast Years: 10 Years
Base Revenue
Revenue Growth Rate
Low
Mid
High
Final Net Margin
Low
Mid
High
Final P/E Ratio
Low
Mid
High
Discount Rate

Peter Lynch Fair Value

Earnings Per Share
Growth Rate
Low
Mid
High

Graham Formula

Earnings Per Share
EPS Growth (7-10 years)
Low
Mid
High
Government Bond Rate

Growth Estimates

Revenue

CAGR-3.3%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$63.70(B)
FY+1
25
2%
$62.24(B)
FY+2
25
4%
$59.84(B)
FY+3
22
8%
$55.05(B)
FY+4
14
3%
$53.51(B)
FY+5
14
1%
$53.91(B)

Net Income

CAGR26.0%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$4.33(B)
FY+1
24
292%
$16.98(B)
FY+2
24
3%
$16.50(B)
FY+3
21
14%
$14.20(B)
FY+4
12
7%
$13.25(B)
FY+5
12
4%
$13.76(B)

EPS

CAGR25.9%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$0.76
FY+1
25
292%
$2.98
FY+2
25
3%
$2.90
FY+3
19
15%
$2.47
FY+4
12
6%
$2.31
FY+5
12
4%
$2.40

FCF per share

CAGR7.2%
TTMFY+1FY+2FY+3FY+4FY+5
TTM
$1.93
FY+1
8
71%
$3.30
FY+2
8
1%
$3.28
FY+3
8
8%
$3.02
FY+4
7
3%
$2.94
FY+5
7
7%
$2.73

Historical Financials (in USD)

Income(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.020.0(B)40.0(B)60.0(B)80.0(B)
Revenue Operating Income Net IncomeCOGSGross ProfitTotal OpEx.R&DSG&AInterest ExpenseInterest IncomeOther Non-operating IncomePre-tax incomeIncome tax
Cash flow(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.05.0(B)10.0(B)15.0(B)20.0(B)25.0(B)
Stock-based Comp. FCFCFONet IncomeD&AChange in Working CapitalCFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.050.0(B)100.0(B)150.0(B)200.0(B)
Total Assets Total LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EIntangible AssetsGoodwillCurrent liabilitiesShort-Term DebtAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Per share data(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.01.02.03.04.05.0
EPS (Basic) FCF/Share Dividend/ShareEPS (Diluted)Book value/ShareCash & ST inv./ShareDebt/Share
Ratios(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.05.010.015.020.0
P/E P/S EV/EarningsP/FCFP/BDebt/EquityPayout ratio
Margins(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0%20%40%60%80%
Net Income Margin Operating Margin Gross MarginEBITDA Margin
Returns(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0%5%10%15%20%
ROIC ROAROCEROE
Shares outstanding(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.01.0(B)2.0(B)3.0(B)4.0(B)5.0(B)
Shares (Basic)Shares (Diluted)
Market Cap.(show more...)
Q3'20 (TTM)Q3'21 (TTM)Q3'22 (TTM)Q3'23 (TTM)Q3'24 (TTM)Q3'25 (TTM)0.050.0(B)100.0(B)150.0(B)200.0(B)
Market Cap.

PFE vs Peers

Similar Companies

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.10%
Institutions: 70.28%
Other: 29.63%

Institutional ownership

9.29% Blackrock Inc.6.48% Vanguard Capital Manag...5.39% State Street Corporati...2.34% Geode Capital Manageme...2.05% Vanguard Portfolio Man...1.91% Fisher Asset Managemen...1.63% Morgan Stanley1.09% Northern Trust Corpora...1.02% Bank Of New York Mello...0.99% Massachusetts Financia...38.09% Others

Trading Summary

In the past year, insiders have bought a net of $1.82(M).

Total insider buys: $1.96(M)
Total insider sells: $134661

In the past year, Congress members have sold a net of $223004.

Total congressional buys (avg): $8001
Total congressional sells (avg): $231004

Based on the reported ranges: buys $1001–$15000, sells $107008–$355000.

Insider transactions

$0.002026-10$0.00
$0.002026-09$0.00
$832612026-08$1.96(M)
$0.002026-07$0.00
$514002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$0.002026-01$0.00
$0.002025-12$0.00
$0.002025-11$0.00
$0.002025-10$0.00
DateSharesTotal ($)Price ($)NameTitle
Buy2026-08-0537,632960,36925.5BUCKLEY MORTIMER J.Director
Buy2026-08-0539,231998,82125.5BLAYLOCK RONALD EDirector
Sell2026-08-053,27883,26125.4DAMICO JENNIFER B.Officer
Sell2026-06-092,00051,40025.7DAMICO JENNIFER B.Officer
Grant2026-03-0321,71900.0DAMICO JENNIFER B.Officer
Grant2026-02-2513,38300.0BOSHOFF CHRISTOFFELOfficer
Grant2026-02-2537,9251,282,62433.8MCDERMOTT MICHAELOfficer
Grant2026-02-2517,558593,81233.8DAMICO JENNIFER B.Officer
Grant2026-02-2556,8881,923,95233.8SAHNI PAYALOfficer
Grant2026-02-25491,62616,626,79133.8BOURLA ALBERTChief Executive Officer
Grant2026-02-2556,8881,923,95233.8FONSECA LIDIA PH.D.Officer
Grant2026-02-25122,9074,156,71533.8LANKLER DOUGLAS MOfficer

Congressional trading

$0.002026-10$0.00
$0.002026-09$0.00
$0.002026-08$0.00
$0.002026-07$0.00
$0.002026-06$0.00
$0.002026-05$0.00
$0.002026-04$0.00
$0.002026-03$0.00
$0.002026-02$0.00
$160012026-01$0.00
$1830012025-12$0.00
$0.002025-11$8001
$0.002025-10$0.00
DatePoliticianPartyChamberAmount ($)
Sell2026-01-22Ro KhannaDHouse$1,001 - $15,000
Sell2026-01-22Ro KhannaDHouse$1,001 - $15,000
Sell2025-12-31J. French HillRHouse$100,001 - $250,000
Sell2025-12-19Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Buy2025-11-18Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Sell2025-09-15Ro KhannaDHouse$1,001 - $15,000
Sell2025-09-15Ro KhannaDHouse$1,001 - $15,000
Sell2025-09-15Ro KhannaDHouse$1,001 - $15,000
Sell2025-09-05Ro KhannaDHouse$1,001 - $15,000

Tools

Dividend Income

Investment Amount
Dividend Yield
What is the Dividend Income Calculator?

The Dividend Income Calculator helps you estimate the yearly, quarterly, monthly, and daily income of your investments.

How to Use This Calculator?

Enter the dividend yield and the invested amount. Optionally, preload stock data to automatically fetch the dividend yield.

Required Investment

Dividend Yield
Desired Yearly Payout
Desired Quarterly Payout
Desired Monthly Payout
What is the Required Investment Calculator?

The Required Investment Calculator helps you determine the amount of money you need to invest in a stock to achieve a desired dividend.

How to Use This Calculator?

Enter the dividend yield and your desired dividend income. Optionally, preload stock data to automatically fetch the dividend yield.

Future Dividend Yield

Base Dividend
Current Price
Number of Years
Dividend Growth Rate
What is the Future Yield Calculator?

The Future Yield Calculator helps you estimate the future dividend yield of a stock based on its current dividend, price, and expected dividend growth rate.

How to Use This Calculator?

Enter the base dividend, current price, number of years, and dividend growth rate. Optionally, preload stock data to automatically fetch the dividend and price. The calculator will display the current yield and the projected future yield.

Future Dividend Income

Base Dividend
Number of Years
Dividend Growth Rate
What is the Future Dividend Income Calculator?

The Future Dividend Income Calculator helps you estimate the future dividend income from your investments based on the current dividend yield and expected growth rate.

How to Use This Calculator?

Enter the current dividend yield, expected growth rate, and investment duration. Optionally, preload stock data to automatically fetch the dividend yield.

(C) PEVALUATOR
About
Terms & privacy
Price charts & news courtesy of TradingView
Blog
Contact